Trial Outcomes & Findings for Safety and Tolerability Study of Antimicrobial TheraGauze for Skin Abscess (NCT NCT02334384)

NCT ID: NCT02334384

Last Updated: 2018-10-04

Results Overview

Evaluate for evidence of side-effects from Antimicrobial TheraGauze packing of skin abscess wounds compared with standard of care (i.e. cotton wick or iodoform wick). Tests for statistical significance will be made for multiple potential side-effects including: 1) erythema around the wound packing, 2) increased pain at the wound site, 3) increased tenderness around the wound 4) increased discharge from the wound, 4) new rash, and 5) fever.

Recruitment status

COMPLETED

Study phase

PHASE1/PHASE2

Target enrollment

6 participants

Primary outcome timeframe

1 week

Results posted on

2018-10-04

Participant Flow

Participant milestones

Participant milestones
Measure
Antimicrobial TheraGauze
Antimicrobial TheraGauze (i.e. tobramycin impregnated TheraGauze) will be used as a wound packing after incision and drainage of skin abscess (i.e. furunculosis). Antimicrobial TheraGauze will be administered once. Antimicrobial TheraGauze: In the intervention arm: Antimicrobial TheraGauze, tobramycin impregnated TheraGauze, will be used to pack the wound cavity after incision and drainage of the skin abscess. In the comparator arm: Standard wound packing, plain cotton wick or iodoform gauze - at the discretion of the provider will be used to pack the wound cavity after incision and drainage of the skin abscess.
Standard Wound Packing
Standard wound packing will be used as the active comparator. The ED physician will have the choice to use plain cotton wick or iodoform wick. Standard wound packing will be administered once. Antimicrobial TheraGauze: In the intervention arm: Antimicrobial TheraGauze, tobramycin impregnated TheraGauze, will be used to pack the wound cavity after incision and drainage of the skin abscess. In the comparator arm: Standard wound packing, plain cotton wick or iodoform gauze - at the discretion of the provider will be used to pack the wound cavity after incision and drainage of the skin abscess.
Overall Study
STARTED
4
2
Overall Study
COMPLETED
3
1
Overall Study
NOT COMPLETED
1
1

Reasons for withdrawal

Reasons for withdrawal
Measure
Antimicrobial TheraGauze
Antimicrobial TheraGauze (i.e. tobramycin impregnated TheraGauze) will be used as a wound packing after incision and drainage of skin abscess (i.e. furunculosis). Antimicrobial TheraGauze will be administered once. Antimicrobial TheraGauze: In the intervention arm: Antimicrobial TheraGauze, tobramycin impregnated TheraGauze, will be used to pack the wound cavity after incision and drainage of the skin abscess. In the comparator arm: Standard wound packing, plain cotton wick or iodoform gauze - at the discretion of the provider will be used to pack the wound cavity after incision and drainage of the skin abscess.
Standard Wound Packing
Standard wound packing will be used as the active comparator. The ED physician will have the choice to use plain cotton wick or iodoform wick. Standard wound packing will be administered once. Antimicrobial TheraGauze: In the intervention arm: Antimicrobial TheraGauze, tobramycin impregnated TheraGauze, will be used to pack the wound cavity after incision and drainage of the skin abscess. In the comparator arm: Standard wound packing, plain cotton wick or iodoform gauze - at the discretion of the provider will be used to pack the wound cavity after incision and drainage of the skin abscess.
Overall Study
Lost to Follow-up
1
1

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Antimicrobial TheraGauze
n=4 Participants
Antimicrobial TheraGauze (i.e. tobramycin impregnated TheraGauze) will be used as a wound packing after incision and drainage of skin abscess (i.e. furunculosis). Antimicrobial TheraGauze will be administered once. Antimicrobial TheraGauze: In the intervention arm: Antimicrobial TheraGauze, tobramycin impregnated TheraGauze, will be used to pack the wound cavity after incision and drainage of the skin abscess. In the comparator arm: Standard wound packing, plain cotton wick or iodoform gauze - at the discretion of the provider will be used to pack the wound cavity after incision and drainage of the skin abscess.
Standard Wound Packing
n=2 Participants
Standard wound packing will be used as the active comparator. The ED physician will have the choice to use plain cotton wick or iodoform wick. Standard wound packing will be administered once. Antimicrobial TheraGauze: In the intervention arm: Antimicrobial TheraGauze, tobramycin impregnated TheraGauze, will be used to pack the wound cavity after incision and drainage of the skin abscess. In the comparator arm: Standard wound packing, plain cotton wick or iodoform gauze - at the discretion of the provider will be used to pack the wound cavity after incision and drainage of the skin abscess.
Total
n=6 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=4 Participants
0 Participants
n=2 Participants
0 Participants
n=6 Participants
Age, Categorical
Between 18 and 65 years
4 Participants
n=4 Participants
2 Participants
n=2 Participants
6 Participants
n=6 Participants
Age, Categorical
>=65 years
0 Participants
n=4 Participants
0 Participants
n=2 Participants
0 Participants
n=6 Participants
Age, Continuous
33 years
STANDARD_DEVIATION 12 • n=4 Participants
33 years
STANDARD_DEVIATION 12 • n=2 Participants
33 years
STANDARD_DEVIATION 12 • n=6 Participants
Sex: Female, Male
Female
3 Participants
n=4 Participants
1 Participants
n=2 Participants
4 Participants
n=6 Participants
Sex: Female, Male
Male
1 Participants
n=4 Participants
1 Participants
n=2 Participants
2 Participants
n=6 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Region of Enrollment
United States
4 Participants
n=4 Participants
2 Participants
n=2 Participants
6 Participants
n=6 Participants
Diameter of induration
32.5 mm
n=4 Participants
27.5 mm
n=2 Participants
30.8 mm
n=6 Participants

PRIMARY outcome

Timeframe: 1 week

Evaluate for evidence of side-effects from Antimicrobial TheraGauze packing of skin abscess wounds compared with standard of care (i.e. cotton wick or iodoform wick). Tests for statistical significance will be made for multiple potential side-effects including: 1) erythema around the wound packing, 2) increased pain at the wound site, 3) increased tenderness around the wound 4) increased discharge from the wound, 4) new rash, and 5) fever.

Outcome measures

Outcome measures
Measure
Antimicrobial TheraGauze
n=4 Participants
Antimicrobial TheraGauze (i.e. tobramycin impregnated TheraGauze) will be used as a wound packing after incision and drainage of skin abscess (i.e. furunculosis). Antimicrobial TheraGauze will be administered once. Antimicrobial TheraGauze: In the intervention arm: Antimicrobial TheraGauze, tobramycin impregnated TheraGauze, will be used to pack the wound cavity after incision and drainage of the skin abscess. In the comparator arm: Standard wound packing, plain cotton wick or iodoform gauze - at the discretion of the provider will be used to pack the wound cavity after incision and drainage of the skin abscess.
Standard Wound Packing
n=2 Participants
Standard wound packing will be used as the active comparator. The ED physician will have the choice to use plain cotton wick or iodoform wick. Standard wound packing will be administered once. Antimicrobial TheraGauze: In the intervention arm: Antimicrobial TheraGauze, tobramycin impregnated TheraGauze, will be used to pack the wound cavity after incision and drainage of the skin abscess. In the comparator arm: Standard wound packing, plain cotton wick or iodoform gauze - at the discretion of the provider will be used to pack the wound cavity after incision and drainage of the skin abscess.
Number of Side-effects
4 Participants
2 Participants

Adverse Events

Antimicrobial TheraGauze

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Standard Wound Packing

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Kenji Cunnion

Eastern Virginia Medical School

Phone: 7574465125

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place